PSI Developed A New Promising Radiopharmaceutical Successfully Tested A promising radiopharmaceutical against metastatic neuroendocrine tumours has been successfully tested for the first time in patients at the University Hospital Basel, Switzerland. The new radionuclide terbium-161 was developed at the Paul Scherrer Institute (PSI, ENS Corporate Member). This isotope has the property that when the radioisotope…
ENS HSC Position Paper “Nuclear Scientific Community for Global Sustainable Development” This interview has been published on NucNet – The Independent Nuclear News Agency, on 20th March 2024. NucNet is a Brussels-based independent news agency and information network for the global nuclear industry. It operates a 24/7 service reporting nuclear-related news about the operation and…
Urenco Signed An Important Nuclear Fuel Deal With Korea’s KHNP On Friday 22 March, Urenco (ENS Corporate Member) signed a new contract for the long-term supply of enrichment services with the operator of Korea’s nuclear power plants – Korea Hydro & Nuclear Power Company (KHNP) – helping to provide a secure, diverse and reliable supply…
Tractebel To Support PanTera’s Radioisotope Production Facility Tractebel (ENS Corporate Member), together with its partner MODULO architects, will support the design and construction of PanTera’s actinium-225 production facility in Belgium, enabling breakthrough cancer treatments. The PanTera facility will be built in Mol (Belgium) and is dedicated to the production of 225Ac via photonuclear activation on…
Framatome To Support Sizewell C Project In The UK Framatome (ENS Corporate Member) has signed several contracts with Sizewell C Ltd. to support the new nuclear build project in the UK. This signing follows the British Government Investment Decision in November 2022 to approve the construction of two EPR reactors at Sizewell on the Suffolk…
Support For Nuclear Energy Remains Strong In Finland The support for nuclear energy as a reliable and safe low-carbon source of energy remains high in Finland. A new survey by Verian, commissioned by Finnish Energy, reports that 61 % of respondents are in favour of nuclear power and only 9 % against. The current approval…
European Commission Approves State Measures Supporting NUWARD Project The European Commission has approved, under EU State aid rules, a €300 million French measure to support NUWARD – EDF (ENS Corporate Member) subsidiary – in researching and developing small modular nuclear reactors (SMRs). The measure will contribute to achieving the strategic objectives of the European industrial strategy and…
UK Gov’t Supports Urenco in Building An Advanced Fuels Facility The UK Government announced funding of £196m (€227.5m) to Urenco (ENS Corporate Member) to support the building of an advanced fuels facility at the Capenhurst enrichment site in the northwest of England. This will help to facilitate the Department of Energy Security and Net Zero’s…
“Advancing Healthcare” Exploring the Frontiers of Nuclear Medicine In the field of healthcare innovation, nuclear medicine and radiopharmaceuticals stand out for their remarkable contributions to diagnosis and treatment. These technologies offer personalized approaches and targeted therapies, which are revolutionizing patient care. However, to ensure access to these cutting-edge treatments for all, it’s crucial to support…
Considerations on the Resilience and Potential Risks of the Zaporizhzhia NPP Against Drone Attacks Prof. Dr. Attila Aszódi Thirty-eight years ago, on 26 April 1986, the Chernobyl nuclear power plant accident, the largest nuclear accident in history, occurred in the then-Soviet Union, now Ukraine. The accident attracted enormous attention and its serious consequences have become…